Excellent posts, Doug Diamond.You've hit the nail on the head...

Excellent posts, Doug Diamond.

You've hit the nail on the head re. Edwards.

Scenario 1, Acquire Anteris and watch their revenues and profits escalate massively, long into the future.

Scenario 2, Let somebody else acquire Anteris and become an irrelevancy, revenues and profits obliterated, market cap decimated, and a major sector of their employees disbanded.

The DurAVR has been described by some of the world's greatest cardio-thoracic doctors as transformational, a game-changer and a once in a generation technology.

The results in the limited patients to date are congruent with the words and descriptions of these doctors.

And in the right hands, the DurAVR will come to dominate and own the TAVR field and also a large % of the SAVR field.

The outcomes facing Edwards are clear..... Death or Glory.

How much will they pay?

I believe they will pay whatever it takes and ultimately whatever they can! Survival is a strong motivator!